SUBSCRIBE
SUBSCRIBE

Fibrodysplasia Ossificans Progressiva

PRESS RELEASES
Press Releases
Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
February 19, 2026
 · 
12 min read
Press Releases
Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP)
December 19, 2025
 · 
7 min read
Press Releases
Canada’s $1.5-billion Rare Disease Drug Strategy generating ‘return on investment’ for patients and society but more needs to be done
November 26, 2025
 · 
4 min read
Press Releases
Regeneron Reports Third Quarter 2025 Financial and Operating Results
October 28, 2025
 · 
31 min read
Press Releases
Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal Bone Formation
September 18, 2025
 · 
15 min read
Press Releases
Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics
June 16, 2025
 · 
6 min read
Press Releases
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
December 23, 2024
 · 
3 min read